FDA approves over-the-counter head lice lotion
The U.S. Food and Drug Administration (FDA) approved the over-the-counter (OTC) use of a lotion designed to treat head lice. Read More »
FDA issues warning for pregnant women who take some pain, fever medications after 20 weeks
The U.S. Food and Drug Administration (FDA) recently released a warning for pregnant mothers regarding a family of medications that includes ibuprofen, naproxen, diclofenac, celecoxib and other nonsteroidal anti-inflammatory drugs (NSAIDs). Read More »
Pharmacists may qualify for NIH student loan repayments up to $100,000
The National Institute of Health (NIH) has recently expanded options for pharmacists to engage in their Loan Repayment Programs (LRPs), and can apply by Friday, Nov. 20 for this year’s programs. Read More »
FDA approves drug combination that treats mesothelioma
The U.S. Food and Drug Administration (FDA) announced the approval of Opdivo (nivolumab) combined with Yervoy (ipilimumab) for first-line treatment of adults who have malignant pleural mesothelioma that cannot use alternative methods for removal such as surgery. Read More »
FDA approves use of XELJANZ on children
The U.S. Food and Drug Administration (FDA) recently approved Pfizer’s drug XELJANZ (tofacitinib) for treatment of polyarticular course juvenile idiopathic arthritis (pcJIA). Read More »
Trial shows promise for Eli Lilly-developed breast cancer treatment
Eli Lilly and Company’s phase 3 monarchE trial of their cancer treatment drug Verzenio® (abemaciclib) has demonstrated a significant decrease risk of breast cancer recurrence for patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) high risk early breast cancer. Read More »
ASHP responds to petition calling for an end to gender discrimination in the pharmacy industry
The American Society of Health-System Pharmacists (ASHP) recently released a response to a petition calling for an end to gender inequality in the clinical pharmacy industry. Read More »
Leonard named new president of the Association for Accessible Medicines
Dan Leonard formerly president and CEO of the National Pharmaceutical Council (NPC) has been named new president and CEO of the Association for Accessible Medicines, members of the AAM board announced on Aug. 25. Read More »
Best in health care showcased in 2020 We Work for Health Champion Awards
This year's We Work for Health Champion Awards honors many individuals that have done tremendous work in the health care industry this year, especially with COVID-19 presenting a new and unique situation. Read More »
Cost of sharing assistance program threatened by administration actions
The high costs of medical care are well-documented, but those battling significant illnesses have found a measure of economic relief through manufacturer cost-sharing assistance programs. Read More »
PhRMA exec optimistic on COVID-19 vaccine
The push for a COVID-19 vaccine is “remarkably positioned to succeed,” Jenny Bryant, executive vice president of policy and research for the Pharmaceutical Research and Manufacturers of America (PhRMA), said. Read More »
Health care organizations call for Congress to recognize pharmacists as providers of billable services
A recent letter to Congressional leaders from a coalition headed by the National Forum for Heart Disease and Stroke Prevention urges Congress to include payments for front-line pharmacists in the next COVID-19 relief package by designating them as providers under Medicare Part B. Read More »
AEI expert calls for coordinated world effort to distribute COVID-19 vaccine
James Capretta, a resident fellow and health analyst with the American Enterprise Institute (AEI), a Washington D.C.-based think tank that researches government, economics and social welfare, called for a coordinated effort to distribute vaccine worldwide to prevent COVID-19 infection. Read More »
Grein: Those suffering from COVID-19 receiving experimental treatments
The majority receiving COVID-19 experimental treatments are those patients hospitalized with the coronavirus, Cedars-Sinai Hospital Epidemiology Director Jonathan Grein said in a recent news release. Read More »
States are using the health care system to battle opioid use disorder
To control the opioid crisis, states are developing programs within the health care system to fight opioid use disorder (OUD) by increasing both the access to and quality of available treatment for those afflicted. Read More »
Pharmaceutical companies want intellectual property protections to be key focus
Several pharmaceutical companies are staying vigilant in their commitment to finding proper treatments and vaccine research and development (R&D) related to COVID-19, according to PhRMA. Read More »
Pharmaceutical industry works to find COVID-19 vaccine
Six months into the COVID-19 pandemic, pharmaceutical companies join forces to develop drugs and vaccines to eliminate the virus. Read More »
Hospital pharmacists more involved in patient care, survey finds
Hospital pharmacists are becoming more involved in patient care and are embracing new technology, a new study found. Read More »
Groups voice opposition to Trump's 'Buy America' proposals for drug supply chain
An increasing number of groups are voicing their opposition to proposals by the Trump administration to force drug companies and medical device manufacturers to source materials in the United States, according to one trade organization. Read More »
Moderna could soon have vaccine candidate for COVID-19
While the development of COVID-19 vaccines is still in the early stages, a set of data from Moderna shows promising signs of efficacy, Managed Healthcare reported. Read More »
Alerts Sign-up